[1]
M. H. Secrest, MSc, S. Phillips, MPH, M. S. Cepeda, MD, PhD, D. M. Kern, MS, PhD, D. B. Esposito, MPH, PhD, and G. P. Wedin, PharmD, “Impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategy on prescribing practices”, J of Opioid Management, vol. 19, no. 2, pp. 99–110,A1, Mar. 2023.